N, I., T, S., Y, I., H, A., T, N., T, T., & S, N. (2021). A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis. Dove Medical Press.
Cita Chicago Style (17a ed.)N, Ishii, Shimizu T, Ishiura Y, Amuro H, Nishizawa T, Tamaki T, y Nomura S. A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis. Dove Medical Press, 2021.
Cita MLA (8a ed.)N, Ishii, et al. A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis. Dove Medical Press, 2021.